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Keratoconus (KC) affects 152000 people and is a disorder where cornea thins and assumes a conical shape.
Advanced KC requires surgery to maintain vision. The role of oxidative stress in KC remains unclear. We
aimedtoidentifyoxidativestresslevelsbetweenhumancornealkeratocytes(HCKs),fibroblasts(HCFs)and
keratoconus cells (HKCs). Cells were cultured in 2D and 3D systems. Vitamin C (VitC) and TGF-b3 (T3)
were used for 4 weeks to stimulate self-assembled extracellular matrix (ECM). No T3 used as controls.
Samples were analyzed using qRT-PCR and metabolomics. qRT-PCR data showed low levels of collagen I
andV,aswellaskeratocanforHKCs,indicatingdifferentiationtoamyofibroblastphenotype.Collagentype
III,amarkerforfibrosis,wasupregulated inHKCs.Werobustlydetectedmorethan150metabolitesof the
targeted 250 by LC-MS/MS per condition and among those metabolites several were related to oxidative
stress. Lactate levels, lactate/malate and lactate/pyruvate ratios were elevated in HKCs, while arginine and
glutathione/oxidized glutathione ratio were reduced. Similar patterns found in both 2D and 3D. Our data
shows that fibroblasts exhibit enhanced oxidative stress compared to keratocytes. Furthermore the HKC
cells exhibit the greatest level suggesting they may have a myofibroblast phenotype.
K
eratoconus(KC)isaprogressivedegenerativediseaseandisamajorclinicalproblemworldwide.KCaffects
4 to 600 per 100,000 people and in advanced cases can lead to severe loss of vision. KC affects the cornea
structurally, causing it to thin, weaken and protrude into a more conical shape. While KC appears in the
teenage years to young adulthood, its rate of progression is generally unpredictable. Currently, the use of contact
lenses is used at the early stages of the disease, whereas advanced stages often require surgery, such as corneal
transplantation, to maintain or improve vision. Surgeries, however, do not come without complications, which
include vascularization of the corneal tissue and rejection of the donor cornea. Corneal collagen crosslinking
(CXL) is a new upcoming treatment for keratoconus disease where riboflavin is added to the cornea and is
activated by ultraviolet (UV) light
1,2. Riboflavin has been shown to increase collagen crosslinking in the cornea
andincreaseitsstrengthleadingtolessdeformation.ThepathogenesisofKCisstillunclear,however,avarietyof
factorshavebeenconsidered,includinggeneticsandcellularmechanisms,aswellasoxidativestress
3–9.Oneofthe
fewrecognizedlinkstoKCdiseaseistheassociationofindividualswithDownsyndrome.Approximately,15%of
the individuals with Down syndrome exhibit KC disease
6,10. The common gene defect between the two is the
superoxide dismutase-1 (SOD1) where ithas been proposed as apossible candidate gene forfamilial KC
11.Other
genedefectsassociatedwithKCdiseaseincludeVSX1,COL6A1,COL8A1,andMMP9asreviewedbyNowakand
Gajecka
12.
Oxidative stress is an indication of the accumulation of reactive oxygen species (ROS) that may lead to
disturbances in the normal redox state of the cell and cause a toxic effect by free radicals and damage all cellular
components, including DNA, proteins and lipids. In humans, oxidative stress has been linked to a variety of
diseases, such as cancer
13, Parkinson’s disease
14, heart failure
15, and myocardial infraction
16,17. In KC, the mRNA
levels of antioxidant enzymes have been investigated
18 in KC cornea buttons. The authors concluded that KC
corneas undergo oxidative stress and tissue degradation. In agreement with this study, are several others where
the antioxidant activities as well as protein levels have been investigated
19,20.
Previously, we used a novel 3D model to study KC, which utilizes human keratoconus cells (HKCs) incubated
inthepresenceofastabilizedderivativeofVitaminC(VitC)andTGF-b3(T3).UndertheseconditionstheHKCs
deposited an extracellular matrix (ECM) that resembles normal stromal ECM
21. In that study HKCs without T3
secreted an ECM with fibrotic characteristics.
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SCIENTIFIC REPORTS | 4 : 4608 | DOI: 10.1038/srep04608 1Targetedmetabolomics using massspectrometry hasbeen usedto
profile many diseases such as cancers from biological tissue sources
such as cerebral spinal fluid (CSF), plasma and tumor tissue
22–25.I n
our current study, we investigated the metabolic differences between
human corneal keratocytes (HCKs), fibroblasts (HCFs) and HKCs,
under conventional 2D cultures and using our 3D in vitro model.
Investigating both systems allow us to compare cells in a monolayer
culture and cells in a self-assembled ECM, which more resembles an
in vivo like condition. From these studies, our data indicated that
HKCs express metabolites that are indicative of oxidative stress both
in the 2D and 3D cultures.
Results
Cell morphology and real time-PCR. We investigated the morpho-
logy of the three cell types. Both HKCs and HCFs were elongated or
fibroblastic in appearance, while the HCKs were dendritic in shape.
Figure 1 shows the morphological phenotype of HKCs which is very
similar to HCFs as we have shown previously
28. In 3-D cultures,
HCKs maintained their dendritic morphology and were distinc-
tively different from HCFs as previously shown
28. The morpholo-
gical characteristics were maintained both with cells in culture and
cellsonpolycarbonatemembranes.Wedidnotnoticeanysignificant
morphological changes between initial cell expansion and experi-
mental conditions.
Wefurthercharacterizedthecellsbyinvestigatingseveralessential
probeswithqRT-PCRforcornealstromalcells:ColI,IIIandV.ColI
and V are routinely found in healthy adult corneal stroma, whereas
Col III is a sign of myofibroblast differentiation and a wounded/
scarred cornea. We have shown previously
28 that Col I and V (,4–
5 fold) are significantly upregulated in HCKs and HCFs when T3 is
present, independent of VitC stimulation
28. In Table 1 we compared
the two cell types to HKCs. Expression levels of Col I and Col V, for
HKCs, were identical to HCFs; however a 4 fold decrease was seen
when compared to HCKs for both Col I and -V. Col III (Table 1)
expressionwassignificantly higher(,4fold)withHKCswhencom-
pared to HCFs and even more so when compared to HCKs (,108
fold). Since Col III is a marker for corneal fibrosis and myofibroblast
populationpresence,thisisindicativeofthedifferentcellularstateof
the KC corneas. Our data suggest that HKC are myofibroblasts in
agreementtopreviousstudywherehighsmoothmuscleactin(SMA)
expression was shown
21.
Predicted Pathways of Regulation. Our system allows us to investi-
gate the levels of various metabolites, both in cells that are conven-
tionally cultured (2D), as well as in self-assembled 3D ECM. From
our overall raw data analysis, we observed that out of 249 targeted
metabolites, the number of those robustly detected ranged from 127
to155acrossthe samples withameanvalue of144.InFigure 2and 3
the predicted metabolic pathways that are affected based on the raw
data is shown in 2D (Figure 2) and 3D (Figure 3) systems. When we
analyzed the metabolites that were up regulated by at least 2-fold in
HKCscomparedtoHCKsanumberofpathwaysthatareinvolvedin
oxidative stress were affected. Examples are the citric acid cycle, the
glycine-serine-threonine, the betaine and the glutathione metabo-
lism. On the other hand, based on the metabolites where HCKs
expressed in higher levels than HKCs, our software indicated
significant regulation of pathways that are mainly involved in cell
growth (biotin metabolism), toxicity protection (ammonia metabo-
lism, and apoptosis prevention (ubiquinone biosynthesis). Based on
these results we further analyzed the metabolites involved in
oxidative stress.
Lactate: Cells and Constructs. Our system allows us to investigate
the levels of variousmetabolites, both incells that are conventionally
cultured (2D), as well as in self-assembled 3D ECM. Lactate is
produced from pyruvate via glycolysis and is an important
metabolite that has been implicated in corneal edema
31, When
lactate levels are high, corneal edema appears. High lactate levels
are also a hallmark of many diseases and lactate has become a
potential target for cancer therapies
32. Figure 4 shows a clear
difference in lactate levels between cells cultured in monolayer
(2D) and stratified cultures (3D). Lactate levels were significantly
(p,0.05) higher when cells were allowed to develop their own
ECM and grow in an environment that mimics the in vivo. HKC
were significantly higher than both HCFs and HCKs. T3 stimulation
onlysignificantlyaffectedHCFs(p,0.05)witha2foldupregulation
of lactate levels. HKCs showed down regulation of lactate (p,0.05)
with the same T3 treatment. Similarly, in the monolayer system,
HCKs maintained the lowest levels of lactate when compared to
both HCFs and HKCs.
Lactate/Malate ratio: Cells and Constructs. Lactate has been linked
to oxidative stress and when paired with other specific metabolites,
can act as an indicator of oxidative stress
33. One such combination is
the lactate-malate ratio (L/M), which is known to be a critical
regulator of oxidative stress
34,35. Malate is an intermediate in the
citric acid cycle (or TCA cycle) produced from fumerate and an
indicator of citric acid cycling. In vivo, the degree of elevation of
the ratio and its timing are related to the severity of hypoxia and
oxidativestress
35.Inoursystems,HCKsshowedthelowestL/Mratio
independent of condition and treatment (Figure 5), when compared
to both HCFs (p,0.05) and HKCs (p,0.01). In agreement with our
lactate data, HKCs seem to be under more oxidative stress. This is
enhanced in the 3D system where there is a significant 4 fold
difference from the HCF (p,0.01). When HCFs were treated with
Figure 1 | Representative imageshowing themorphology of HKCs in3D
cultures. HKCs maintained fibroblastic, elongated morphology under all
conditions. Red 5 Phalloidin, Blue 5 TOPRO-3. Bars 5 50 microns.
Table 1 | qRT-PCR analysis for all three cell types HCKs, HCFs, and
HKCs for Collagen-I, -III and -V. Col I and Col V expression was
down-regulated4foldinHCFsandHKCswhencomparedtoHCKs.
ColIIIwassignificantlyhigher(,4fold)withHKCswhencompared
to HCFs and 108 fold compared to HCKs
Collagen-I
(RQ Mean)
Collagen-III
(RQ Mean)
Collagen-V
(RQ Mean)
HCK 11.46 6 0.68 0.07667 6 0.0016 11.43 6 0.2706
HCF 2.84 6 0.30 2.27 6 0.15 1.773 6 0.1877
HKC 2.763 6 0.29 8.637 6 0.61 3.12 6 0.26
www.nature.com/scientificreports
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regulation in 2 (p,0.05) and 3D system (p,0.01) respectively. L/
M ratio, on the other hand, was reduced in HKCs (p,0.05). Overall,
HKCs abnormal levels of oxidative stress are enhanced in the 3D
cultures, which is a system more accurately mirroring in vivo
regulations (Figure 5). Lactate/malate can indicate the relative
levels of glycolytic activity to TCA cycle activity.
Lactate/Pyruvate ratio: Cells and Constructs. Pyruvate represents
thefinalstepofglycolysisandaprecursortolactate.Therelativeratio
oflactate/pyruvate(L/P)hasbeenusedasameasureofanaerobicand
aerobic corneal metabolism. However, the ratio also has been
proposed as an indicator of oxidative stress
28. An increase in the L/
P ratio has been reported to accompany corneal degradation and
oxidative stress
33. Figure 6 shows ratio regulation on both our
systems for all cell types. HCKs showed the lowest ratio of L/P in
both systems and all conditions (p,0.001). HKC on the other hand
displayed the greatest up regulation of L/P (p,0.0001) in the 3D
model indicating oxidative stress. Upon T3 stimulation L/P levels
were positively affected and significantly down regulated (p,0.001).
Figure 2 | Summaryofpathwayenrichmentanalysisin2Dsystem.Aboveisadisplayofthediversityofsignalingpathwaysthatareenrichedonthebasis
of all the metabolites passing filtering criteria. The most significant p-values are in red while the least significant are in yellow and white. A) Shows
pathways affected based on metabolites that were at least 2-fold down-regulated in HKCs compared to HCKs, B) Shows pathways affected based on
metabolites that were at least 2-fold up-regulated in HKCs compared to HCKs.
Figure 3 | Summaryofpathwayenrichmentanalysisin3Dsystem.Aboveisadisplayofthediversityofsignalingpathwaysthatareenrichedonthebasis
of all the metabolites passing filtering criteria. The most significant p-values are in red while the least significant are in yellow and white. A) Shows
pathways affected based on metabolites that were at least 2-fold down-regulated in HKCs compared to HCKs, B) Shows pathways affected based on
metabolites that were at least 2-fold up-regulated in HKCs compared to HCKs.
www.nature.com/scientificreports
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the 3D model for the HCKs. No differences were seen for the HCF
which showed identical regulation on all systems and conditions.
GSHratios:CellsandConstructs.Anotherwaytomeasurelevelsof
oxidative stress is by looking at a highly studied antioxidant and
metabolite glutathione. Glutathione exists in both reduced (GSH)
and oxidized (GSSG) states. A decreased GSH-to-GSSG ratio is
considered indicative of oxidative stress
36,37. In the keratoconic
cornea, levels of GSH are low in central corneal buttons
38. In this
study, we investigated the level of GSH-to-GSSG ratio in our 2D and
3D systems. (Figure 7) The lowest ratio of GSH-to-GSSG was
detected in the HKCs (p,0.05) under all systems and conditions,
indicating that the cells were and remained under oxidative stress.
On the other hand the highest ratio, not surprisingly, was seen with
HCKs (p,0.05) indicating less oxidative stress levels. Unlike other
indicatorssofar,suchaslactate,L/MandL/Pratios(Figures4,5,and
6 respectivelly), the 3D system seemed to recover some of the HKCs
stress levels, i.e under less oxidative stress. Figure 7 shows higher
values of GSH-to-GSSG ratio for all three cell types in the 3D
system compared to 2D (p,0.05). T3 treatment significantly
increased the ratio values for HCKs (p,0.05) and HCFs (p,0.05),
but not for HKCs. Overall, our data throughout showed that HKCs
aredistinctfrombothHCKsandHCFsandareundermoreoxidative
stress regardless of which system is used (2D or 3D).
Arginine: Cells and Constructs. Arginine is another important
metabolite that has been linked to oxidative stress. In the cornea,
arginine is a key player in the overall immune privilege of the eye.
Inhibition of arginine has been shown to accelerate graft rejection
39.
We investigated the regulation of arginine in our systems and the
resultsareshowninFigure8.Asexpected,HCKsargininelevelswere
significantly higher than HCFs and HKC (p,0.01), however that
was only for the 2D system. In the 3D model, HCKs and HKCs
showed similar levels where HCFs were significantly lower. This is
anothermetabolitewhereitsexpressionisregulateddifferentlywhen
the cells secrete their own ECM versus the conventional cell culture
2Dmodel.WhilethereisaclearindicationthatHKCs’argininelevels
arelowerthanthenativeHCKs,andthereforeunderoxidativestress,
our data with T3 is somewhat confusing. In 2D, HCKs showed a
massivedownregulationofarginine,whereHCFsandHKCsdidnot;
where in 3D the effect was inverted with a big up regulation of
arginine expression in HCKs. Clearly the role of T3 in oxidative
stress regulation is not well understood and further characteriza-
tion is currently under way.
Figure 4 | Lactate metabolite regulation in 2D and 3D culture models for
HCKs,HCFs,andHKCs.Twoconditionswereexaminedandanalyzedfor
all cell types: Control: VitC only, and T3:VitC 1 TGF-b3. Lactate levels
were significantly (p,0.05) higher in 3D systems compared to 2D. Upon
T3 stimulation only HCFs showed significant up-regulation of Lactate
levels (p,0.05).
Figure 5 | Lactate to Malate metabolite ratio (L/M) in 2D and 3D culture
models for HCKs, HCFs, and HKCs. Two conditions were examined and
analyzed for all cell types: Control:VitC only, and T3:VitC 1 TGF-b3.
HCKsshowedthelowestL/Mratiounderallconditionscompared toboth
HCFs (p,0.05) and HKCs (p,0.01). T3 significantly increased L/M ratio
in HCFs (p,0.01) and decreased it in HKCs (p,0.01).
Figure 6 | LactatetoPyruvatemetaboliteratio(L/P)in2Dand3Dculture
models for HCKs, HCFs, and HKCs. Two conditions were examined and
analyzed for all cell types: Control:VitC only, and T3:VitC 1 TGF-b3.
HCKsshowedthelowestratioofL/Punderallconditions(p,0.001).HKC
displayedthegreatestupregulationofL/P(p,0.0001)inthe3Dmodel.T3
stimulation reversed that (p,0.001).
Figure 7 | Glutathione reduced (GSH) to Glutathione oxidized (GSSG)
ratio(GSH-to-GSSG)in2Dand3DculturemodelsforHCKs,HCFs,and
HKCs. Two conditions were examined and analyzed for all cell types:
Control:VitConly,andT3:VitC1TGF-b3.HKCsshowedthelowestratio
under all conditions (p,0.05). T3 treatment significantly increased the
ratio values for HCKs (p,0.05) and HCFs (p,0.05), but not for HKCs.
www.nature.com/scientificreports
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Despite the huge advancements in technology, very little is known
about metabolic activity of corneal cells derived from Keratoconus
patients. This is surprising considering that metabolomics has been
used successfully in ocular diseases
19,20,31,39,40. We therefore investi-
gatedthemetabolicactivityofcornealcellsderivedfrombothnormal
individual as well as Keratoconus patients. In order to more accur-
atelyquantifymetabolicactivityandcorrelateittowhatishappening
in vivo weused two in vitro models; a) conventional 2D cultures and
b)a3Dinvitromodelthatwepreviouslyestablished
27asanovelway
to study keratoconus disease at the cellular level in vitro. Our data
clearly shows that HKCs are significantly different in terms of their
metabolism in vitro, when compared to corneal fibroblasts. Specific
metabolites that are known to be key players in oxidative stress were
up regulated with HKCs as compared to HCFs indicating oxidative
stress status. In turn, both of these cell types were different from
normalkeratocytes. Almostallmetabolitestested here indicated that
HCKs were under less stress when compared to either HCFs or
HKCs.
Oxidative stress is defined as the imbalance between the systemic
manifestation of reactive oxygen species and a biological system’s
ability to detoxify or repair any resulting damage from the reactive
intermediates
41. In humans, oxidative stress depends on the size of
thesechanges and whether the cellcan overcome them and return to
its original stage. One of the main sources of reactive oxygen is the
leakageof activatedoxygen frommitochondriaduring themetabolic
pathway of oxidative phosphorylation
42. The role of the mitochon-
dria in energy metabolism and oxidative stress has been well estab-
lished
43–45. It appears to be intimately linked to their generation of
ROS that play a regulatory role in cellular metabolic processes. In
fact, the majority of ROS are products of mitochondrial respiration.
ROS production and oxidative stress have been linked with an array
of pathologies, including type II diabetes, atherosclerosis, ischemia/
reperfusion injury, and others
46–48.
In ocular surface there have been multiple reports about oxidative
stress, including keratoconus. Chwa and co-authors
49 reported that
KCfibroblastshaveaninherent,hypersensitiveresponsetooxidative
stressors that involves mitochondrial dysfunction and mtDNA
damage. Nguyen and co-workers
40 recently showed that lactate
transport was a significant component in the corneal endothelial
pump and cornea edema in vivo could be avoided if high levels of
lactate were cleared, this was in agreement with previous studies by
Klyce
31. In our system, lactate levels were higher for the Keratoconus
cells in the 3D model when compared to Fibroblasts and in both 2D
and 3D systems when compared to keratocytes. Fu and coworkers
showed that another metabolite, arginine, plays a key role in cornea,
andtheoverallimmuneprivilegeoftheeyeinvivo
39.Arginineinhibi-
tion led to accelerated corneal graft rejection. Our data shows that
keratocytes had higher level of arginine than both fibroblasts and
keratocytes. HCK Control and T3 treated seem to be significantly
regulated between the two systems. Taking these together it is clear
that Keratoconus cell metabolism is different from normal corneal
keratocyte and may provide clues to diagnose and treatment of the
disease. Interestingly, both lactate and arginine have been previously
linked to corneal edema and thinning
31,39,40,50 which are characteris-
tics of Keratoconus disease.
Another metabolite that we identified with abnormal levels in the
HKCs was glutathione (GSH), an antioxidant peptide that prevents
cellular damage from oxidative stress
51. This is in agreement with
previous studies showing that GSH contribute to corneal degenera-
tion in keratoconus
52,53. In order to ensure accuracy of our results we
plotted ratios of GSH with other metabolites that are known to be a
sign of oxidative stress such as malate and pyruvate. In all cases
HKCs showed such levels suggesting that were under more stress
than keratocytes.
The cornea is a transparent avascular tissue that absorbs approxi-
mately 80% of the incident ultraviolet B (UVB) light
54, making it
highly sensitive and vulnerable to damage from free radicals and
ROS
54,55. In the healthy cornea, there are a number of defensive
mechanisms that are present to minimize and reduce the risk of
oxidative damage
53,56. A variety of antioxidant enzymes are present
such as catalase, glutathione peroxidase, and glutathione reductase
ensuringtheremovalofROSgeneratedbyUVlightexposure
57.Cells
will also defend themselves with enzymes such as alpha-1-microglo-
bulin, superoxide dismutases, glutathione peroxidases and peroxi-
doxins
58,59. Small molecules antioxidants such as Vitamin C,
topopherol, and glutathione also play a vital role in the cornea s
defense mechanism.
Collectively our data shows that cells derived from Keratoconus
patients are under oxidative stress both in conventional 2D model as
wellaswhentheysecretetheirownECM(ie3Dmodel).Ourpathway
prediction software supports this conclusion, as many of the altered
pathways in HKCs were oxidative stress related. While this is pre-
dictive software it gives us a good indication when alterations
between cell types are present. Based on these results future studies
should help identify and characterize specific pathways that poten-
tially might lead to metabolic therapies for keratoconus. This is a
novel way to study the metabolism of these cells and identify the key
players that can help us understand the mechanism behind this
disease.Ongoingstudiesaimtoidentifymorekeymetabolitesaswell
as further characterize the role of TGF-b3 in regulating metabolism.
Form the data shown here T3 seems to have differential effect on
multiple metabolites making its role hard to identify.
Methods
Primary cultures of Human Corneal Keratocytes (HCK), Fibroblasts (HCF) and
Keratoconus cells (HKC). HCKs and HCFs were isolated from human corneas from
healthy patients without ocular disease. All samples were obtained from NDRI
(NationalDiseaseResearchInterchange;Philadelphia,PA).HKCswereisolatedfrom
humancorneasfrompatientswithKeratoconusdefects.Thesesampleswereobtained
from Ula Jurkunas (Massachusetts Eye and Ear Infirmary, Boston, MA, USA) and
Jesper Hjortdal (Aarhus University Hospital, Aarhus, Denmark). All research
adhered to the tenets of the Declaration of Helsinki. Tissue was processed, as
previously described
26. Briefly, corneal epithelium and endothelium were removed
from the stroma by scraping with a razor blade. The stromal tissue was then cut into
,2 3 2 mm pieces and placed into T25 culture flasks. Explants were allowed to
adhere to the bottom of the wells and then Eagle’s Minimum Essential Medium
(EMEM: ATCC; Manassas, VA) with either 1% (HCKs) or 10% (HCFs and HKCs)
fetal bovine serum (FBS: Atlantic Biologicals; Miami, FL) was added. Following 1–2
weeks of cultivation, the cells were passaged into 100 mm cell culture plates and
allowed to grow to 100% confluence before being used in our two systems (2D and
3D).
Conventional 2D cultures. All cell types (HCKs, HCFs and HKCs) were cultured on
conventional 6-well tissue culture plates and processed for qRT-PCR. Cells were
seeded at 10
6 cells/well and cultured in EMEM with either 1% (HCKs) or 10% FBS
Figure 8 | Arginine metabolite regulation in 2D and 3D culture models
forHCKs,HCFs,andHKCs.Twoconditionswereexaminedandanalyzed
for all cell types: Control:VitC only, and T3:VitC 1 TGF-b3. HCKs
arginine levels were significantly higher than HCFs and HKC (p,0.01)
only for the 2D system.
www.nature.com/scientificreports
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MN); (Vit C: 0.5 mM 2-O-a-D-glucopyranosyl-L-ascorbic acid: Wako Chemicals
USA, Inc.; Richmond, VA). Cultures without T3 served as Controls (C).
Real time PCR (qRT-PCR). Total RNA was extracted and processed, and qRT-PCR
was performed, as previously described
21.Total RNA was extracted from the cells
using GeneJet RNA Purification Kit (GeneJet RNA Purification Kit:
ThermoScientific, K0731). Genomic DNA was removed by incubation with RNase-
freeDNaseI(NewEnglandBioLabs,M0303S)inthepresenceofRNaseinhibitor.The
RNA was annealed with oligo dt and random hexamer primers, and first strand
synthesis was carried out with MuLV reverse transcriptase (Life technologies, Grand
Island,NY).Negativecontrolswereperformedwithoutreversetranscriptase.AVii7A
(Life technologies, Grand Island, NY) was used to perform the qRT-PCR with ABI
TaqMan gene expression assays—Col1A1: Hs00164004_m1, Col3A1:
Hs00943809_m1, Col5A1: Hs00609088_m1, and Keratocan: Hs00559942_m1 and
the Eukaryotic 18S rRNA Endogenous Control, 4308329. Results were calculated
using the DDCt method, using 18S rRNA as the endogenous control.
Assembly of Extracellular Matrix – 3D constructs. As previously described
21,27,28,
cells were plated on transwell 6-well plates containing polycarbonate membrane
inserts with 0.4 mm pores (Costar; Charlotte, NC) at a density of 10
6 cells/ml. Cells
were cultured in EMEM with either 1% (HCKs) or 10% FBS (HCFs and HKCs) 1
VitC 6 T3 (0.1 ng/ml). The cultures were allowed to grow for 4 weeks. The optimal
concentration of T3 was previously determined by comparing a concentration series
ranging from 0.1–10 ng/ml
27.Cultures withoutT3served as Controls (C). Constructs
thicknesses were similar with our previous studies
21,27,28.
Metabolite extraction. All tissues were collected and processed as previously
reported
24,29.Briefly, samples were grounded using a homogenizer in ice-cold 80%
MeOH. Samples were centrifuged (14,000 g, 10 min, 4uC) and supernatants
incubated on dry ice. Pellets were further disrupted in ice-cold 80% MeOH and
combined with previous supernatants. Plasma metabolites were extracted twice in
80% ice-cold MeOH. Metabolite extracts were vortexed and centrifuged (14,000 g,
10 min, 4uC). Supernatants were evaporated and stored at 280uC until further
analysis.
Targeted Mass Spectrometry. Samples were re-suspended using 20 mL HPLC grade
water for mass spectrometry, and 5–7 ml was injected into a hybrid 5500 QTRAP
triple quadrupole mass spectrometer (AB/SCIEX) coupled to a Prominence UFLC
HPLC system (Shimadzu, Columbia, MD)
24,29. Samples were analyzed via selected
reactionmonitoring(SRM)ofatotalof256endogenouswatersolublemetabolitesfor
steady-state analyses. Some metabolites were targeted in both positive and negative
ion mode, for a total of 289 SRM transitions, using positive/negative ion polarity
switching. ESI voltage was 14900 V in positive ion mode and 24500 V in negative
ion mode. The dwell time was 3 ms per SRM transition and the total cycle time was
1.55 seconds. Approximately 10–14 data points were acquired per detected
metabolite. Samples were delivered to the mass spectrometer via hydrophilic
interaction chromatography (HILIC) using a 4.6 mm i.d 3 10 cm Amide XBridge
column (Waters) at 375 ml/min. Gradients were run as follows: 1) 0–5 minutes with
85to42%bufferB(HPLCgradeacetonitrile),;2)5–16minuteswith42to0%bufferB;
3)16–24minuteswith0%bufferB;4)24–25minuteswith0to85%bufferB;and5)7
minuteswith85%bufferB.Thislaststepwastore-equilibratethecolumn.Peakareas
from the total ion current for each metabolite SRM transition were integrated using
MultiQuant v2.0 software (AB/SCIEX).
Pathway Enrichment Analysis. Pathway enrichment (representation) analysis was
performed using an online freeware program; Metaboanalyst (www.Metaboanalyst.
ca) intended for the analysis of metabolomics data.
30 Briefly, we performed the
analysis using only the metabolites that were up or down regulated by 2-fold as
indicated by our statistical analysis. We chose 2-fold cutoff in order to ensure that we
includedonlythevastlyabundantmetabolites.Onlymetabolitesthatwerepresenton
all biological samples were considered for further analysis. The metabolites that
passed our criteria were inputinto the software and the pathway enrichmentanalysis
was run. The output of this algorithm marks a metabolic pathway if the input list of
the metabolites suggests that the pathway associated with a specific pathway are
present at levels that would not be expected by random chance.
StatisticalAnalysis.Allexperimentswererepeatedatleastthreetimes(threeseparate
donors)anddatawasanalyzedforsignificantvariations(p,0.05)usingtheStudent’s
t-test and Dunnett’s Multiple Comparison test.
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